ReNeuroGen Revenue

Pharmaceutical Manufacturing • Elm Grove, Wisconsin, United States • 1-10 Employees

ReNeuroGen revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$821,328
Total funding	$75,000

Key Contact at ReNeuroGen

Stephen Naylor

CEO

Company overview

Headquarters	Elm Grove, Wisconsin, United States
Phone number	+14129720134
Website	rngen.com
NAICS	3254
Founded	2016
Employees	1-10
Socials

ReNeuroGen Email Formats

ReNeuroGen uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@rngen.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@rngen.com	66.7%
{first name}.{last name}	john.doe@rngen.com	33.3%

About ReNeuroGen

A virtual pharmaceutical company developing systems pharmacology therapies with a focus on neurological and pulmonary disease indications.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

ReNeuroGen has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore ReNeuroGen's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-10	9	$75,000

Funding Insights

$75,000

Total funding amount

$75,000

Most recent funding amount

Number of funding rounds

ReNeuroGen Tech Stack

Discover the technologies and tools that power ReNeuroGen's digital infrastructure, from frameworks to analytics platforms.

Sirvoy

Appointment scheduling

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Microsoft 365

Frequently asked questions

ReNeuroGen is located in Elm Grove, Wisconsin, US.

You can reach ReNeuroGen at +14129720134.

ReNeuroGen generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

ReNeuroGen has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ReNeuroGen was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

ReNeuroGen has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

ReNeuroGen has raised a total of $75,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at ReNeuroGen

Stephen Naylor

CEO

4.8

40,000 users